Global Anti-Adhesion Barrier Gels Industry Geared for a Noteworthy 8.4% CAGR Surge, Enrooted to Exceeding US$ 209.8 Million by 2032 | FMI Unveils

Global Anti-Adhesion Barrier Gels Industry

Future Market Insights (FMI), a leading provider of market intelligence and consulting services, reveals promising projections for the Global Anti-Adhesion Barrier Gels Industry. According to FMI’s latest industry analysis, the market is valued at approximately US$ 93.4 Million in 2022 and is anticipated to experience a robust Compound Annual Growth Rate (CAGR) of nearly 8.4% over the forecast period, reaching an estimated valuation of US$ 209.8 Million by 2032.

An essential component in post-surgical healing, adhesion barriers recognized by the FDA play a pivotal role in separating internal tissues and organs, thereby reducing abnormal internal scarring known as adhesions. The industry sees diverse offerings, including gels and sheets, manufactured by various companies and employed across a spectrum of surgical procedures.

Commonly composed of sodium hyaluronate, Carboxymethylcellulose, or oxidized regenerated cellulose, commercially available anti-adhesion materials, particularly those containing hyaluronic acid, exhibit a notable penetration rate in orthopedic procedures. With a consistent rise in the number of patients undergoing fracture repair surgery and coronary artery bypass grafting globally, the demand for these products is expected to soar.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15678

During surgeries such as abdominal surgery, adhesion formation is a very common complication, wherein more than 90% of the patients develop intra-abdominal adhesions post-surgery. This leads to issues like infertility, small bowel obstruction, pelvic pain, etc. Moreover, many times, there are readmissions about these issues while many require further surgery which raises the difficulty and duration of these surgeries, thereby affecting patient’s quality of life significantly.

The use of cutting-edge technologies by surgeons to treat post-surgical adhesion has opened up new opportunities for pharmaceutical businesses to generate income. Since there is no specific medication available for the prevention of surgical adhesions, using adhesion barrier gels is an efficient strategy to lessen or avoid the incidence, extent, severity, and concerns of post-surgical adhesions.

Because adhesive barriers are the only treatment option for post-surgical adhesions, demand for adhesion barriers is anticipated to increase over the projected period.

Key Takeaways from the Global Anti-Adhesion Barrier Gels Industry Study

  • Hyaluronic acid is the leading segment by product, and held a 2% market value share in 2021, owing to its usage in surgeries and sport-related injuries.
  • Surgical Applications held a market share of 3% in 2021 owing to a rise in surgeries in different sectors such as cardiology, neurology, and others.
  • By end user, hospitals are leading in the Global Anti-Adhesion Barrier Gels Industry, and are expected to continue to do so with a projected CAGR rate of 9% during the forecasted years.
  • North America is considered the leading region with a value share of 5% in 2021, owing to the large number of manufacturers and growing patient pool in the region.

Examining the study’s underlying assumptions. Ask the Expert:
https://www.futuremarketinsights.com/ask-question/rep-gb-15678

“Rising number surgical procedures along with growing demand for adhesion barriers post-surgery is set to propel the sales of anti-adhesion barrier gels across the globe,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Global Anti-Adhesion Barrier Gels Industry Competition

Investing in business inorganically has been the hallmark of bringing strong business growth and most players in the adhesion barriers market are following this trend, which directly contributes to revenue growth, increasing product portfolio, and expanding presence and distribution network in different geographies. The general competitive environment in the Global Anti-Adhesion Barrier Gels Industry is characterized by consolidation activities such as joint ventures and new product launches.

  • On January 26, 2020, Terumo Launched a New Surgical Sealant AQUABRID® in the EMEA Market.
  • In Jan 2017, Terumo acquired brands from Abbott Laboratories. The two brands namely Angio-Seal and FemoSeal, vascular closure devices are expected to boost Terumo’s existing product portfolio in growing segments through both in-house development and external investment

Key Market Players:

  • LG Chem Life Sciences Company
  • Anika Therapeutics
  • FzioMed, Inc.
  • Normedi Nordic
  • Betatech
  • Bioscompass
  • Klas
  • Terumo
  • BioRegen Biomedical
  • CGBIO
  • Shing Poong Pharma Co.LTD
  • Hangzhou Singclean Medical Products Co., Ltd.
  • General
  • Kieron
  • Hanohai Biological
  • PlantTec Medical GmbH

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15678

Key Market Segments Covered in the Global Anti-Adhesion Barrier Gels Industry Research

By Product:

  • Hyaluronic acid
  • Carboxymethylcellulose
  • polyethylene oxides

By Application:

  • Surgical Applications
    • Urological & Gynecological Surgeries
    • Orthopedic Surgeries
    • Abdominal surgeries
    • Neurological Surgeries
    • Cardiovascular Surgeries
    • Reconstructive and Plastic Surgeries
    • Others
  • Trauma Cases

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these